Cost analysis of ovarian cancer chemotherapy based on the use of a chemoresponse assay
Publication
, Journal Article
Havrilesky, LJ; Krivak, TC; Mucenski, JW; Myers, ER
Published in: GYNECOLOGIC ONCOLOGY
February 1, 2009
Duke Scholars
Published In
GYNECOLOGIC ONCOLOGY
ISSN
0090-8258
Publication Date
February 1, 2009
Volume
112
Issue
2
Start / End Page
S22 / S22
Publisher
ACADEMIC PRESS INC ELSEVIER SCIENCE
Related Subject Headings
- Oncology & Carcinogenesis
- 3215 Reproductive medicine
- 3211 Oncology and carcinogenesis
- 3202 Clinical sciences
- 1114 Paediatrics and Reproductive Medicine
- 1112 Oncology and Carcinogenesis
Citation
APA
Chicago
ICMJE
MLA
NLM
Havrilesky, L. J., Krivak, T. C., Mucenski, J. W., & Myers, E. R. (2009). Cost analysis of ovarian cancer chemotherapy based on the use of a chemoresponse assay. GYNECOLOGIC ONCOLOGY, 112(2), S22–S22.
Havrilesky, L. J., T. C. Krivak, J. W. Mucenski, and E. R. Myers. “Cost analysis of ovarian cancer chemotherapy based on the use of a chemoresponse assay.” GYNECOLOGIC ONCOLOGY 112, no. 2 (February 1, 2009): S22–S22.
Havrilesky LJ, Krivak TC, Mucenski JW, Myers ER. Cost analysis of ovarian cancer chemotherapy based on the use of a chemoresponse assay. GYNECOLOGIC ONCOLOGY. 2009 Feb 1;112(2):S22–S22.
Havrilesky, L. J., et al. “Cost analysis of ovarian cancer chemotherapy based on the use of a chemoresponse assay.” GYNECOLOGIC ONCOLOGY, vol. 112, no. 2, ACADEMIC PRESS INC ELSEVIER SCIENCE, Feb. 2009, pp. S22–S22.
Havrilesky LJ, Krivak TC, Mucenski JW, Myers ER. Cost analysis of ovarian cancer chemotherapy based on the use of a chemoresponse assay. GYNECOLOGIC ONCOLOGY. ACADEMIC PRESS INC ELSEVIER SCIENCE; 2009 Feb 1;112(2):S22–S22.
Published In
GYNECOLOGIC ONCOLOGY
ISSN
0090-8258
Publication Date
February 1, 2009
Volume
112
Issue
2
Start / End Page
S22 / S22
Publisher
ACADEMIC PRESS INC ELSEVIER SCIENCE
Related Subject Headings
- Oncology & Carcinogenesis
- 3215 Reproductive medicine
- 3211 Oncology and carcinogenesis
- 3202 Clinical sciences
- 1114 Paediatrics and Reproductive Medicine
- 1112 Oncology and Carcinogenesis